ARCHIVES

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010